Cefdinir for Oral Suspension USP recall
Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Mandideep, 462 046 India, NDC 68180-723-04
Why was Cefdinir for Oral Suspension USP recalled?
Defective container: lack of seal integrity.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #F305184, F305185, F305186, Exp 7/31/ 2025
- Product
- Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Mandideep, 462 046 India, NDC 68180-723-04
- Recalling firm
- Lupin Pharmaceuticals Inc.
- Quantity
- 51,006 bottles
- Distribution
- USA Nationwide
- Recall date
- June 5, 2024
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)